New antiviral drug cuts cytomegalovirus infection, improves survival in patients undergoing donor stem cell transplant – Science Daily
OncLive |
New antiviral drug cuts cytomegalovirus infection, improves survival in patients undergoing donor stem cell transplant
Science Daily In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital (BWH) has shown that a novel agent can protect against the most … Dr. Marty on Letermovir for CMV Prevention After Stem Cell Transplant Letermovir Prevents CMV Infection Post-HSCT in Phase 3 Study Positive Phase III Data for Merck Candidates against CMV and Shingles |
